NMA: Nonprescription Medicines Academy

Recent Self Care News

  • Pharmacy-Based Intervention Addresses Gaps in Osteoarthritis Patient Care

    A multidisciplinary, pharmacy-based intervention to improve health outcomes for patients with undiagnosed knee osteoarthritis produced significant increases in more than half of the Arthritis Foundation quality indicators.

    October 17th, 2012

  • Updated Clinical Practice Guideline Urges Antimicrobial Therapy Only for Confirmed Cases of Streptococcal Pharyngitis

    The new Infectious Diseases Society of America guideline on diagnosis and management of Group A streptococcal pharyngitis (“strep throat”) urges physicians to refrain from prescribing antimicrobial agents for pharyngitis unless the results of rapid antigen detection testing confirm the presence of group A streptococcus.

    October 17th, 2012

  • Consumers Hear Less About Medication Risks After Rx-to-OTC Switch

    Direct-to-consumer drug advertisements contain significantly less information about potential risks after a prescription medication becomes available for nonprescription use, based on an analysis of print and broadcast ads for loratadine, omeprazole, orlistat, and cetirizine.

    October 17th, 2012

  • Omega-3 Supplements Do Not Reduce Risk of Major Cardiovascular Events

    A systematic review and meta-analysis of 20 studies encompassing more than 68,000 patients found no significant associations between omega-3 polyunsaturated fatty acids (PUFAs) supplementation and a lower risk of all-cause mortality, cardiac death, sudden death, myocardial infarction, or stroke.

    October 17th, 2012

  • Study Finds Waning Protection from DTaP Vaccine

    A case-control study that assessed the risk of pertussis (whooping cough) in children 4 to 12 years of age revealed waning disease protection during the 5 years after a fifth dose of diphtheria–tetanus–acellular pertussis (DTaP) vaccine, such that the odds of acquiring pertussis increased by an average of 42% each year.

    October 17th, 2012

  • Meta-Analysis: Acetaminophen Has Minimal Effects on Serum ALT Levels in Drinkers

    In a systematic review and meta-analysis of randomized, placebo-controlled trials that included 551 moderate-to-heavy alcohol users, daily administration of acetaminophen at or near the maximum recommended dose (4 g/day) had minimal effects on serum alanine aminotransferase (ALT) levels when measured on study day 4.

    October 17th, 2012

  • Quick Takes

    • Oxytrol could become first nonprescription medication for the treatment of overactive bladder in women
    • Evidence for use of black cohosh to control symptoms of menopause is inconclusive
    • Creatine monohydrate appears to augment antidepressant efficacy of escitalopram
    • Evidence supports use of topical antibiotics for acute, minor, uncomplicated soft tissue wounds
    • NSAIDs increase coronary risk regardless of time elapsed after myocardial infarction
    • No association found between incidence of breast cancer and use of aspirin, other NSAIDs, or acetaminophen
    • Vaccine finder available through HealthMap.org website
    • American Academy of Pediatrics publishes updated recommendations for prevention and control of influenza in children

    October 17th, 2012

  • New Product Alerts

    • Prilosec OTC
    • Bayer Migraine Formula
    • Chloraseptic Warming Sore Throat Spray
    • Linzess (linaclotide)

    October 17th, 2012

  • Patient Safety Alerts

    • FDA warns about burns from topical analgesics
    • FDA expands caution about Simply Thick

    October 17th, 2012

  • Upcoming Health Observances

    • American Pharmacists Month
    • American Diabetes Month
    • Gastroesophageal Reflux Disease Awareness Week
    • Great American Smokeout
    • National Handwashing Awareness Week

    October 17th, 2012